ArticleFrontiers in pharmacology2022

Lonafarnib Inhibits Farnesyltransferase via Suppressing ERK Signaling Pathway to Prevent Osteoclastogenesis in Titanium Particle-Induced Osteolysis.

Linke Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.